1 - 15 of 16 Results Clear All
Gladstone researchers are collaborating to solve cardiovascular diseases using new technologies.
Gladstone Experts Research Heart Failure Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Virology and Immunology Bruneau Lab Conklin Lab Krogan Lab
Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.
Grants News Release Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab Srivastava Lab
Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.
Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab
First sequence of the Komodo dragon genome reveals clues about its evolution
News Release Research Congenital Heart Disease Bruneau Lab Pollard Lab Big Data
Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease
Institutional News Congenital Heart Disease Cardiovascular Disease Bruneau Lab
The path to medical breakthroughs lies in bold, ambitious science
Donor Stories Institutional News Spinal Cord Injuries Diabetes Roddenberry Stem Cell Center Bruneau Lab Ding Lab Huang Lab McDevitt Lab Srivastava Lab
Discovery at the Gladstone Institutes will help reevaluate the cause of certain cancers and developmental defects
Bruneau Lab Basic Science
Gladstone’s Bioinformatics Core is dedicated to providing expertise in data analysis and visualization to answer complex biological questions with Big Data.
Bruneau Lab Finkbeiner Lab Big Data
A trio of Gladstone scientists are studying the basic biology of the heart to guide the discovery of new therapies for conditions such as congenital heart disease and heart failure.
Bruneau Lab Haldar Lab Srivastava Lab Basic Science Congenital Heart Disease Heart Failure
Irfan Kathiriya, a visiting scientist at Gladstone, describes how he met his wife in the same lab where he completed his PhD training.
Bruneau Lab
Gladstone has received funding from the National Institutes of Health to continue and expand two exciting projects in cardiovascular research. The funding, totaling more than $6.8 million, supports two teams of scientists and their research on congenital heart disease.
Bruneau Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs Congenital Heart Disease
Discovering the earliest signs of heart development brings us one step closer to our ultimate goal: creating a complete blueprint for building new hearts.
Bruneau Lab
Collaborations have been key to Gladstone’s scientific success since its founding, and its community believes that the biggest challenges in science are better met by bringing together researchers with diverse backgrounds.
Bruneau Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
New gift from long-time supporter William Younger is helping two top scientists repair damaged hearts and prevent damage in developing ones.
Donor Stories Cardiovascular Disease Bruneau Lab Srivastava Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.
Bruneau Lab